Voyager Therapeutics, Inc.
US ˙ NasdaqGS ˙ US92915B1061

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Steven M Paul. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Steven M Paul reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
Director 863,031
Director 41,666
US:KRTX / Karuna Therapeutics, Inc. Director 0
US:SAGE / Sage Therapeutics, Inc. Director 78,539
US:ALNY / Alnylam Pharmaceuticals, Inc. Director 0
US:VYGR / Voyager Therapeutics, Inc. Director 15,000
US:SIAL / Sigma-Aldrich Corporation Director 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Steven M Paul. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas VYGR / Voyager Therapeutics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em VYGR / Voyager Therapeutics, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2016-01-14 VYGR PAUL STEVEN M 10,000 14.0690 10,000 14.0690 140,690 207 16.2600 21,910 15.57

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

VYGR / Voyager Therapeutics, Inc. Insider Trades
Vendas Internas VYGR / Voyager Therapeutics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em VYGR / Voyager Therapeutics, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

VYGR / Voyager Therapeutics, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Steven M Paul conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-05-04 2026-05-04 4 SPTX Seaport Therapeutics, Inc.
Common Stock
C - Conversion 67,031 863,031 8.42
2026-04-30 3 SPTX Seaport Therapeutics, Inc.
Common Stock
796,000
2025-09-15 2025-09-12 4 RAPP Rapport Therapeutics, Inc.
Common Stock
P - Purchase 13,382 41,666 47.31 24.97 334,165 1,040,450
2025-09-15 2025-09-12 4 RAPP Rapport Therapeutics, Inc.
Common Stock
P - Purchase 28,284 28,284 24.50 692,947 692,947
2024-06-06 3 RAPP Rapport Therapeutics, Inc.
Common Stock
477,642
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -35,877 0 -100.00 330.00 -11,839,410
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -30,304 0 -100.00 330.00 -10,000,320
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -30,304 0 -100.00 330.00 -10,000,320
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -33,882 0 -100.00 330.00 -11,181,060
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -10,000 0 -100.00 330.00 -3,300,000
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -8,550 0 -100.00 330.00 -2,821,500
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -2,046 8,550 -19.31 330.00 -675,180 2,821,500
2024-03-04 2024-03-04 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 30,304 30,304
2024-03-04 2024-03-04 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -30,304 2,364 -92.76
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 30,304 32,668 1,281.90
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 30,304 32,668 1,281.90
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -30,304 10,000 -75.19
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -30,304 10,000 -75.19
2024-03-04 2024-02-29 4 KRTX Karuna Therapeutics, Inc.
Common Stock
J - Other 47,378 70,608 203.95 315.18 14,932,598 22,254,229
2024-02-26 2024-02-23 4 KRTX Karuna Therapeutics, Inc.
Common Stock
M - Exercise 4,008 42,114 10.52 99.72 399,678 4,199,608
2024-02-26 2024-02-23 4 KRTX Karuna Therapeutics, Inc.
Common Stock
M - Exercise 27,510 38,106 259.63 7.27 199,998 277,031
2024-02-12 2024-02-09 4 KRTX Karuna Therapeutics, Inc.
Common Stock
F - Taxes -804 10,596 -7.05 317.14 -254,981 3,360,415
2023-02-13 2023-02-09 4 KRTX Karuna Therapeutics, Inc.
Common Stock
A - Award 11,400 11,400
2023-02-13 2022-05-31 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 106,485 106,485
2023-02-13 2022-05-31 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -106,485 0 -100.00
2023-02-13 2022-05-27 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 106,485 106,485
2023-02-13 2022-05-27 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -106,485 0 -100.00
2022-11-30 2022-11-28 4 SAGE Sage Therapeutics, Inc.
Common Stock
J - Other 5 78,539 0.01 38.17 191 2,997,637
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -15,000 0 -100.00
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -175 1,000 -14.89 178.60 -31,255 178,600
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -825 1,175 -41.25 177.58 -146,504 208,656
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -526 2,000 -20.82 176.51 -92,844 353,020
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -90 2,526 -3.44 174.33 -15,690 440,358
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -642 2,616 -19.71 173.06 -111,105 452,725
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,434 3,258 -30.56 172.10 -246,791 560,702
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,235 4,692 -20.84 171.16 -211,383 803,083
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,872 5,927 -45.12 169.71 -826,827 1,005,871
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,948 10,799 -31.42 168.95 -835,965 1,824,491
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -253 15,747 -1.58 166.04 -42,008 2,614,632
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15,000 16,000 1,500.00 11.33 169,950 181,280
2022-02-17 2022-02-16 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 146,900 146,900
2022-01-05 2022-01-04 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 1,638 1,638
2021-11-12 2021-11-09 4 SAGE Sage Therapeutics, Inc.
Common Stock
J - Other 1 1 43.36 43 43
2021-08-18 2021-08-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 1,181 108,849 1.10 106.10 125,304 11,548,879
2021-08-18 2021-08-17 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 1,183 107,668 1.11 105.63 124,960 11,372,971
2021-07-19 2021-07-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4,032 4,032
2021-06-11 2021-06-10 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2021-06-04 2021-06-03 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2021-02-24 2021-02-23 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 161,850 161,850
2021-01-15 2020-03-31 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift 292,207 292,207
2021-01-15 2020-03-31 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift -292,207 0 -100.00
2021-01-15 2020-03-30 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift 292,207 292,207
2021-01-15 2020-03-30 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift -292,207 0 -100.00
2020-12-22 2020-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -15,000 0 -100.00
2020-12-22 2020-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15,000 1,000 -93.75 140.00 -2,100,000 140,000
2020-12-22 2020-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15,000 16,000 1,500.00 9.30 139,500 148,800
2020-07-06 2020-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4,581 4,581
2020-06-30 2020-06-29 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
M - Exercise -292,207 0 -100.00
2020-06-30 2020-06-29 4 KRTX Karuna Therapeutics, Inc.
Common Stock
S - Sale -292,207 106,485 -73.29 103.50 -30,243,424 11,021,198
2020-06-30 2020-06-29 4 KRTX Karuna Therapeutics, Inc.
Common Stock
M - Exercise 292,207 398,692 274.41 0.11 32,143 43,856
2020-06-11 2020-06-09 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2020-06-05 2020-06-04 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2020-02-19 2020-02-14 4 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -140,000 140,000 -50.00
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -30,000 0 -100.00
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -30,000 1,000 -96.77 130.00 -3,900,000 130,000
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 30,000 31,000 3,000.00 14.67 440,100 454,770
2019-07-02 2019-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9,000 9,000
2019-07-02 2019-07-02 4 KRTX Karuna Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -74,294 0 -100.00
2019-07-02 2019-07-02 4 KRTX Karuna Therapeutics, Inc.
Common Stock
C - Conversion 96,485 106,485 964.85
2019-07-01 2019-06-28 4 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -71,121 71,121 -50.00
2019-07-01 2019-06-28 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 3,200 10,000 47.06 23.43 74,976 234,300
2019-07-01 2019-06-28 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 6,800 6,800 22.86 155,448 155,448
2019-07-01 2019-06-27 4 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -616,703 616,703 -50.00
2019-06-17 2019-06-13 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2019-06-06 2019-06-05 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2019-03-22 2019-03-21 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1,967 122,400 -1.58 161.02 -316,726 19,708,848
2019-03-22 2019-03-21 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -2,919 124,367 -2.29 161.05 -470,105 20,029,305
2019-03-22 2019-03-21 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -2,993 127,286 -2.30 161.04 -481,993 20,498,137
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -13,047 130,279 -9.10 161.35 -2,105,133 21,020,517
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -13,096 143,326 -8.37 161.32 -2,112,647 23,121,350
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -16,182 156,422 -9.38 161.20 -2,608,538 25,215,226
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -14,321 172,604 -7.66 161.32 -2,310,264 27,844,477
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -875 186,925 -0.47 161.01 -140,884 30,096,794
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -800 187,800 -0.42 161.02 -128,816 30,239,556
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1,200 188,600 -0.63 161.14 -193,368 30,391,004
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -900 189,800 -0.47 161.01 -144,909 30,559,698
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 190,700 -0.37 161.00 -112,700 30,702,700
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 190,700 -0.37 161.00 -112,700 30,702,700
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 190,700 -0.37 161.00 -112,700 30,702,700
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 192,100 -0.26 161.00 -80,500 30,928,100
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30,600 193,300 18.81
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30,600 193,300 18.81
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30,600 435,477 7.56
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30,600 404,877 8.18
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -122,400 119,295 -50.64
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 70,900 -0.70 161.00 -80,500 11,414,900
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 70,900 -0.70 161.00 -80,500 11,414,900
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 344,177 -0.15 161.00 -80,500 55,412,497
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 344,677 -0.14 161.00 -80,500 55,492,997
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -200 72,900 -0.27 162.00 -32,400 11,809,800
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -200 72,900 -0.27 162.00 -32,400 11,809,800
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -643 73,100 -0.87 161.37 -103,761 11,796,147
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 73,743 -0.67 161.62 -80,812 11,918,639
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12,388 74,443 -14.27 161.02 -1,994,716 11,986,812
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12,044 86,831 -12.18 161.02 -1,939,325 13,981,528
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12,510 98,875 -11.23 161.02 -2,014,360 15,920,852
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12,519 111,385 -10.10 161.02 -2,015,809 17,935,213
2019-02-20 2019-02-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 241,695 241,695
2019-02-20 2019-02-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -241,695 272,777 -46.98
2019-02-14 2018-07-26 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 123,904 123,904
2019-02-14 2018-07-26 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -123,904 0 -100.00
2019-02-14 2018-07-13 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 121,035 123,904 4,218.72
2019-02-14 2018-07-13 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -121,035 514,472 -19.05
2018-06-22 2018-06-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9,000 9,000
2018-06-08 2018-06-06 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2018-03-09 2018-03-07 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 110,000 110,000
2018-03-08 2018-03-06 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -58,139 632,712 -8.42 172.00 -9,999,908 108,826,464
2017-06-08 2017-06-07 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 14,000 14,000
2017-06-06 2017-06-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2017-02-17 2017-01-31 4 SAGE Sage Therapeutics, Inc.
Common Stock
J - Other 2,174 690,851 0.32 3.15 6,848 2,176,181
2017-02-10 2017-02-08 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 240,000 240,000 11.83 2,839,200 2,839,200
2016-06-24 2016-06-22 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 13,922 13,922 28.35 394,689 394,689
2016-06-07 2016-06-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 4,763,954 -0.02
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 4,763,954 -0.02
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 4,763,954 -0.02
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -423 4,763,954 -0.01
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -423 678,569 -0.06
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 678,992 -0.12
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 678,992 -0.12
2016-02-02 2016-02-01 4 VYGR Voyager Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 200,000 200,000 11.09 2,218,000 2,218,000
2016-01-15 2016-01-14 4 VYGR Voyager Therapeutics, Inc.
Common Stock
P - Purchase 10,000 872,351 1.16 14.07 140,690 12,273,106
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
D - Sale to Issuer -624 0 -100.00
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
D - Sale to Issuer -374 0 -100.00
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -4,430 0 -100.00 92.78 -411,015
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -6,800 0 -100.00 74.77 -508,436
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
D - Sale to Issuer -10,000 0 -100.00 71.10 -711,000
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
D - Sale to Issuer -10,000 0 -100.00 69.14 -691,400
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -10,000 0 -100.00 57.76 -577,600
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -10,000 0 -100.00 44.58 -445,800
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -10,000 0 -100.00 57.05 -570,500
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -20,000 0 -100.00 38.71 -774,200
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
Common Stock
D - Sale to Issuer -478 0 -100.00 140.00 -66,920
2015-11-10 3 VYGR Voyager Therapeutics, Inc.
Common Stock
1,724,702
2015-11-10 3 VYGR Voyager Therapeutics, Inc.
Common Stock
1,724,702
2015-09-02 2015-09-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -9,518 683,650 -1.37 52.10 -495,888 35,618,165
2015-09-02 2015-09-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -10,482 693,168 -1.49 52.69 -552,297 36,523,022
2015-08-04 2015-08-03 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -6,020 703,650 -0.85 66.42 -399,848 46,736,433
2015-08-04 2015-08-03 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -9,158 709,670 -1.27 67.05 -614,044 47,583,374
2015-08-04 2015-08-03 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -4,822 718,828 -0.67 67.98 -327,800 48,865,927
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -803 723,650 -0.11 67.46 -54,170 48,817,429
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -9,702 724,453 -1.32 68.12 -660,900 49,349,738
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1,859 734,155 -0.25 68.90 -128,085 50,583,280
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1,600 736,014 -0.22 70.50 -112,800 51,888,987
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -5,336 737,614 -0.72 71.47 -381,364 52,717,273
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 742,950 -0.09 72.44 -50,708 53,819,298
2015-06-15 2015-05-29 4 SIAL SIGMA ALDRICH CORP
Common Stock
G - Gift -7,779 478 -94.21
2015-06-03 2015-06-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -8,705 743,650 -1.16 71.36 -621,153 53,063,815
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -3,291 752,355 -0.44 72.06 -237,162 54,217,560
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -4,604 755,646 -0.61 73.13 -336,710 55,263,641
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -3,400 760,250 -0.45 74.05 -251,774 56,297,425
2015-05-29 2015-05-28 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 13,922 13,922 73.13 1,018,116 1,018,116
2015-05-05 2015-05-01 4 BFAM Sage Therapeutics, Inc.
Common Stock
S - Sale X -20,000 763,650 -2.55 53.31 -1,066,200 40,710,182
2015-04-02 2015-04-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale -20,000 783,650 -2.49 48.51 -970,200 38,014,862
2015-01-28 2015-01-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 1,000 1,000 95.00 95,000 95,000
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
M - Exercise -311 624 -33.26
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
M - Exercise -373 374 -49.93
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock
M - Exercise 311 8,257 3.91
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock
M - Exercise 373 7,946 4.93
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
P - Purchase 10,000 803,650 1.26 18.00 180,000 14,465,700
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock
1,587,300
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock
1,587,300
2014-06-06 2014-06-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15,000 15,000
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
M - Exercise -373 747 -33.30
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
A - Award 935 935
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
A - Award 4,430 4,430
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock
M - Exercise 373 7,573 5.18
2014-01-03 2014-01-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 3,388 3,388
2013-06-10 2013-06-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2013-01-04 2013-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
A - Award 1,120 1,120
2013-01-04 2013-01-02 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
A - Award 6,800 6,800
2012-06-25 2012-06-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2012-05-04 2012-05-02 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
A - Award 10,000 10,000
2012-01-19 2012-01-03 4/A SIAL SIGMA ALDRICH CORP
Common Stock
A - Award 1,200 7,200 20.00
2012-01-05 2012-01-03 4 SIAL SIGMA ALDRICH CORP
Common Stock
A - Award 1,200 2,400 100.00
2011-06-13 2011-06-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15,000 15,000
2011-05-06 2011-05-04 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
A - Award 10,000 10,000 69.14 691,400 691,400
2011-01-05 2011-01-03 4 SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
A - Award 1,200 6,000 25.00 67.30 80,760 403,800
2010-09-24 2010-09-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 30,000 30,000
2010-01-11 2010-01-07 4 SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
A - Award 1,200 4,800 33.33 50.59 60,708 242,832
2009-05-07 2009-05-06 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
A - Award 10,000 10,000 44.58 445,780 445,780
2009-01-06 2009-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock, Par Value $1
A - Award 1,200 1,200
2009-01-06 2009-01-02 4/A SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
A - Award 1,200 3,600 50.00
2006-11-15 3 SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
0
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)